About Occlutech: Founded in Germany in 2003, Occlutech has developed into one of the world's leading companies in structural heart disease over the past decade, developing and supplying ASD, PFO, LAA, PLD and PDA occluders, accessories and a range of innovative special cardiac implant products to more than 50 countries around the world. With over 50.000 implants performed Occlutech is active through its own sales force in Germany, the UK, Italy, France and Scandinavia and through a strong network of distribution partners in the rest of the world.
Occlutech has R&D and manufacturing facilities in Germany, Sweden and Turkey. This allows for fast growth, a flexible, high-paced R&D effort and an efficient lean manufacturing operation, ensuring that products remain affordable while allowing new investment in the company's development pipeline.